Maxacalcitol

Maxacalcitol
Clinical data
Trade names	Oxarol
Other names	22-Oxacalcitriol; OCT
Routes of; administration	IV or topical
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name (1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1S)-1-(3-Hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;
CAS Number	103909-75-7;
PubChem CID	6398761;
IUPHAR/BPS	2784;
DrugBank	DB06272;
ChemSpider	4911262;
UNII	N2UJM5NBF6;
ChEBI	CHEBI:31801;
ChEMBL	ChEMBL333950;
CompTox Dashboard (EPA)	DTXSID4048648 ;
ECHA InfoCard	100.212.050
Chemical and physical data
Formula	C26H42O4
Molar mass	418.618 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@@H]([C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)OCCC(C)(C)O;
	InChI InChI=1S/C26H42O4/c1-17-20(15-21(27)16-24(17)28)9-8-19-7-6-12-26(5)22(10-11-23(19)26)18(2)30-14-13-25(3,4)29/h8-9,18,21-24,27-29H,1,6-7,10-16H2,2-5H3/b19-8+,20-9-/t18-,21+,22+,23-,24-,26+/m0/s1; Key:DTXXSJZBSTYZKE-ZDQKKZTESA-N;

Maxacalcitol (trade name Oxarol) is a vitamin D₃ analog and vitamin D receptor activator (VDRA).^[1] As a pharmaceutical drug, it is used as an injection to treat secondary hyperparathyroidism resulting from hemodialysis and as a topical ointment for psoriasis.^[2]

It was approved for use in Japan in 2010^[3] and in Taiwan in 2018.^[4]

References

^ Mizobuchi M, Ogata H (March 2014). "Clinical uses of 22-oxacalcitriol". Current Vascular Pharmacology. 12 (2): 324–328. doi:10.2174/15701611113119990023. PMID 23713875.
^ "Maxacalcitol". Inxight Drugs. National Center for Advancing Translational Sciences, U.S. National Institutes of Health.
^ "Maxacalcitol". New Drug Approvals in Japan. Kyoto Encyclopedia of Genes and Genomes. D01098.
^ Fukazawa-Shinotsuka M, Saito T, Abe M, Iida S, Wang IT, Terao K, et al. (January 2022). "Maxacalcitol Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis". Drug Research. 72 (1): 23–33. doi:10.1055/a-1581-7609. PMID 34488237.

This dermatologic drug article is a stub. You can help Wikipedia by expanding it.